New carbamate and amino acid derivatives of 7-chloroquinoline were synthesized and characterized using FTIR, 1H NMR, 13C NMR, and HRMS analysis. The synthesized compounds were obtained through a benzotriazole-mediated approach via microwave synthesis and evaluated for antioxidant and anticancer activities. All the synthesized compounds have antioxidant properties though less than those of the standard. Cytotoxic activities of new 7-chloroquinolinyl benzyl amino carbamate derivatives were accessed using LNCaP (Lymph Node Carcinoma of the Prostate), A2780 (human ovarian cancer), and MCF-7 (breast cancer) cell lines. For cytotoxicity research, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was used. The synthesized compounds were subjected to a cell viability assay, and following a 24 h treatment, the IC50 values were determined. Among all the tested compounds, compound 4b demonstrated comparable antitumor activity against LNCaP, A2780, and MCF-7 cell lines when compared to the standard drug docetaxel with IC50 values of 6.61, 2.81, and 5.69 μg/mL for LNCaP, A2780, and MCF-7 cell lines, respectively. A molecular docking study targeting the β-tubulin enzyme revealed that compounds 4a, 4b, and 5b exhibit a high affinity for the taxane binding site and may mimic the action of docetaxel.
31 January 2026 in Archives of Current Medical Research
Background: Cancer is a major health concern with high morbidity and mortality rates, necessitating new treatment strategies. Despite the effectiveness of chemotherapy, drug resistance and side effects pose significant challenges. In recent years, the drug repurposing approach has emerged as a promising strategy for new therapeutic options. SGLT2 inhibitors, originally developed for diabetes treatment, have gained attention for their potential anticancer effects. In this study, the cytotoxic effects of empagliflozin on Caco-2 (colorectal adenocarcinoma), A2780 (ovarian carcinoma), and LNCaP (prostate adenocarcinoma) cell lines were investigated. Methods: In this study, the A2780, LNCaP, and Caco-2 cell lines were utilized. Each cell line was exposed to empagliflozin at varying concentrations of 1, 5, 25, 50, and 100 μM for a duration of 48 hours. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay was employed to evaluate changes in cell viability following treatment. From the cytotoxicity data, the half-maximal inhibitory concentration (IC50) and logIC50 values of empagliflozin were determined to assess its inhibitory effects on cell viability. Results: Empagliflozin significantly reduced cell viability in Caco-2, A2780, and LNCaP cell lines. The most pronounced cytotoxic effect was observed in LNCaP cells, followed by Caco-2 and A2780 cell lines, respectively. Conclusion: These findings suggest that Empagliflozin exhibits cytotoxic effects in certain cancer cell lines and may have potential as an anticancer agent.
17 June 2025 in Journal of Physical Chemistry and Functional Materials
In this study, it was aimed to determine the antiradical, cytotoxic, genotoxic and phytochemical compounds of ethanol, methanol and water extracts of Astragalus compactus Lam. subsp. compactus (guni) plant grown in Elazig. Antiradical activity of the plant was determined against ABTS, DPPH, and OH radicals, and the cytotoxic and genotoxic activities were determined against A2780 and MCF-7 cell lines with MTT and Comet assays. All extracts of A. compactus in all the radical scavenging tests showed lower antiradical activity than the standard antioxidant BHT. However, it was determined that this plant is rich in some important phytochemical compounds, such as phenolic, flavonoid, proanthocyanidin, and phytosterols. DNA damage studies of A. compactus extracts were carried out by the Comet assay and all the results showed that cell death occurred for the A2780 cell lines.
5 February 2026 in Anatolian Journal of Pharmaceutical Sciences
Inflammation is a cancer-related process that contributes to the development and progression of malignancies. Targeting molecules involved in the inflammatory process may be a promising strategy for cancer prevention and treatment. In this context, antihistamines are emerging as a key component of this strategy. Rupatadine (Rup), which specifically targets histamine-1 and platelet-activating factor receptors, is considered a potential therapeutic candidate in this context. This study was conducted to determine the effect of the antihistamine Rup on various cancer cell lines. In the study, human ovarian (A2780), colon (Caco-2) and prostate cancer (LNCaP) cell lines were used. After incubating the cells for 24 hours with Rup concentrations of 1, 5, 25, 50, and 100 µM, cytotoxicity levels were assessed using the MTT assay method. Cell viability results and Rup's inhibitory concentration 50 (IC₅₀) values were calculated using the GraphPad Prism 8 program. Group comparisons were performed using the Kruskal-Wallis H test, and when statistically significant differences were found between groups, multiple comparisons were performed using the Bonferroni-corrected Mann Whitney U test (p< .05). Rup concentrations significantly reduced cell viability in the A2780, Caco-2 and LNCaP cell lines (p< .05). These results indicate that Rup, which exhibits antihistamine activity, may possess anticancer potential and could be considered a therapeutic candidate for various cancer types due to its ability to significantly reduce cell viability in different cancer cell lines.
29 October 2026 in New Trends in Medicine Sciences
Asprosin is a peptide hormone secreted from white adipose tissue during fasting and plays a role in the regulation of energy metabolism. Its ability to cross the blood–brain barrier and exert effects on the central nervous system has attracted attention regarding neurological disorders and brain tumors. Recent studies suggest that asprosin may also be involved in tumor biology. This study investigated the effects of asprosin on cell viability and DNA damage in human glioblastoma (U87-MG) and mouse neuroblastoma (N2a) cell lines. Cells were treated with 1, 10, and 100 ng/mL asprosin. Cell viability was assessed using the 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay, while DNA damage was evaluated by the Comet assay. Data were analyzed using GraphPad Prism 9. One-way analysis of variance (ANOVA) followed by Tukey's post hoc test was used for statistical analysis, and p